Product Overview

Alternative Name: WEE1 HOMOLOG 2, WEE1B, WEE2 Kinase

Development Status: Active Development

Target: Female

Mode: Non-hormonal

Delivery Type: TBD

Duration Type: TBD

Description: WEE2 phosphorylates and inhibits CDC2, which is a catalytic subunit of metaphase promoting factor (MPF) and thus, acts as a negative regulator of oocyte maturation and fertilization. WEE2 is specifically expressed in the oocyte in mice, rhesus macaques, and humans. Inhibition of WEE2 prevents final meiotic maturation of the oocyte (metaphase II arrest) and consequently blocks fertilization.

Updated date: May 30, 2018

Vertical Tabs


Project Phase: Early Development

Project Stage: Lead Optimization

Began discovery in: 2008

Status Details:
  • Studies have demonstrated sole expression of WEE2 in the oocyte in rodents and nonhuman primates. WEE2 knockdown in the oocyte leads to leaky meiotic resumption in the presence of PDE inhibitors, and over-expression of WEE2 causes delayed oocyte maturation under conditions that would otherwise induce meiotic resumption. Results suggest an inhibitory role of WEE2 downstream of cAMP in primates.
  • Verification of activity of lead inhibitors will be accomplished using oocyte culture. Positive results will lead to initial testing using nonhuman primates.

Download Product Report